The size of the Asia Pacific Medical Second Opinion Market is estimated to grow at a healthy CAGR from 2020 to 2025.
Medical Second Opinion refers to an affected person’s act of soliciting for or seeking evaluation of his fitness condition through every other health practitioner or expert to confirm and affirm the analysis and treatment prescribed. This usually happens when the first doctor recommends a complicated/painful surgery or painful and risky approaches. Other situations that propel one to find a second opinion are when the person isn't positive of the prognosis or is unhappy with the treatment plans supplied through the primary medical doctor.
There have been growing instances of hospitals, in particular private ones, being accused of deceiving their patients by jacking up their medical payments. This has led to the development of a web platform where the patient can avail a second opinion from other professional doctors as to whether the treatment path being adopted for them is right.
The worldwide marketplace is emerging at a steady pace with a boom within the wide variety of patients who are willing to take medical insurance and seeking second evaluations for better or opportunity remedy or diagnosis. The advances in telemedicine assist to shut the gaps in healthcare by way of enabling the doctors to attend patient demands in a quick span of time and dispose of the delays in remedy.
This research report segmented and sub-segmented into the following categories:
On the Basis of the region, the market in this region is projected to grow substantially during the forecast period.
Some of the major players in Asia Pacific Medical Second Opinion Market Profiled in the Report are Amradnet, London Pain Clinic, Johns Hopkins USA, Cynergy Care, Bright Grey Royal London Group, Helsana Group, Mendocino County Mental Health, Hyjiya Digital Wellness FZCO, Penn Medicine
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Disease
5.1.1 Cancer
5.1.2 Cardiac Disorders
5.1.3 Diabetes
5.1.4 Injuries
5.1.5 Y-o-Y Growth Analysis, By Disease
5.1.6 Market Attractiveness Analysis, By Disease
5.1.7 Market Share Analysis, By Disease
5.2 Supply provider
5.2.1 Hospitals
5.2.2 Health Insurance Players
5.2.3 Online and Offline Medical Second Opinion Providers
5.2.4 Private clinics
5.2.5 Y-o-Y Growth Analysis, By Supply provider
5.2.6 Market Attractiveness Analysis, By Supply provider
5.2.7 Market Share Analysis, By Supply provider
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.3.5 By Indication
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.4.5 By Indication
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Application
6.1.5.5 By Indication
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 AXA PPP Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Amradnet
8.3 London Pain Clinic
8.4 Johns Hopkins USA
8.5 Cynergy Care
8.6 Bright Grey, Royal London Group
8.7 Helsana Group
8.8 Mendocino County Mental Health
8.9 Hyjiya Digital Wellness FZCO
8.10 Penn Medicine
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
